Mario Schlosser Sells 76,962 Shares of Oscar Health (NYSE:OSCR) Stock

Oscar Health, Inc. (NYSE:OSCR) insider Mario Schlosser sold 76,962 shares of the business’s stock in a transaction that occurred on Tuesday, January 6th. The stock was sold at an average price of $17.01, for a total transaction of $1,309,123.62. Following the completion of the transaction, the insider owned 350,180 shares of the company’s stock, valued at $5,956,561.80. This trade represents a 18.02% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

Mario Schlosser also recently made the following trade(s):

• On Wednesday, December 24th, Mario Schlosser sold 38,835 shares of Oscar Health stock. The shares were sold at an average price of $15.00, for a total value of $582,525.00.
• On Tuesday, December 2nd, Mario Schlosser sold 23,965 shares of Oscar Health stock. The stock was sold at an average price of $16.59, for a total value of $397,579.35.
• On Tuesday, November 11th, Mario Schlosser sold 286,182 shares of Oscar Health stock. The shares were sold at an average price of $15.27, for a total value of $4,369,999.14.

Oscar Health Price Performance

Oscar Health stock opened at $17.68 on Friday. The business’s 50-day simple moving average is $15.80 and its 200 day simple moving average is $16.96. The company has a quick ratio of 0.92, a current ratio of 0.92 and a debt-to-equity ratio of 0.67. The stock has a market cap of $4.68 billion, a price-to-earnings ratio of -15.78 and a beta of 1.90. Oscar Health, Inc. has a 12-month low of $11.20 and a 12-month high of $23.80.

Oscar Health (NYSE:OSCR) last released its earnings results on Thursday, November 6th. The company reported ($0.53) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.55) by $0.02. Oscar Health had a negative net margin of 2.16% and a negative return on equity of 21.50%. The company had revenue of $2.93 billion for the quarter, compared to the consensus estimate of $3.09 billion. During the same period in the prior year, the company posted ($0.22) EPS. The company’s revenue was up 23.2% compared to the same quarter last year. As a group, research analysts anticipate that Oscar Health, Inc. will post 0.69 earnings per share for the current year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in OSCR. SG Americas Securities LLC raised its position in shares of Oscar Health by 886.8% during the fourth quarter. SG Americas Securities LLC now owns 921,288 shares of the company’s stock worth $13,239,000 after purchasing an additional 827,929 shares during the period. Assenagon Asset Management S.A. acquired a new stake in Oscar Health during the 4th quarter worth approximately $9,208,000. IFP Advisors Inc lifted its stake in Oscar Health by 2,762.6% in the third quarter. IFP Advisors Inc now owns 6,498 shares of the company’s stock valued at $123,000 after buying an additional 6,271 shares in the last quarter. Cantor Fitzgerald L. P. boosted its holdings in shares of Oscar Health by 2.2% in the third quarter. Cantor Fitzgerald L. P. now owns 125,144 shares of the company’s stock valued at $2,369,000 after buying an additional 2,637 shares during the period. Finally, CIBC Bancorp USA Inc. bought a new stake in shares of Oscar Health during the third quarter worth $392,000. 75.70% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of research analysts have recently weighed in on the company. Wall Street Zen lowered Oscar Health from a “hold” rating to a “sell” rating in a research report on Saturday, December 6th. Zacks Research raised Oscar Health from a “strong sell” rating to a “hold” rating in a research note on Monday, October 13th. The Goldman Sachs Group started coverage on Oscar Health in a report on Tuesday, October 14th. They set a “neutral” rating and a $17.00 target price on the stock. Piper Sandler upgraded Oscar Health from a “neutral” rating to an “overweight” rating and boosted their target price for the stock from $13.00 to $25.00 in a research report on Tuesday, November 25th. Finally, Weiss Ratings reiterated a “sell (d)” rating on shares of Oscar Health in a research report on Wednesday, October 8th. One investment analyst has rated the stock with a Buy rating, eight have given a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat, the stock has a consensus rating of “Reduce” and a consensus price target of $17.00.

Oscar Health Company Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.